O=C(COC(=O)CNS(=O)(=O)c1ccc(F)c(F)c1F)Nc1ccc(OC(F)F)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?